TCRX vs MSFT: Which Stock is Better?
Side-by-side comparison of Tscan Therapeutics Inc and Microsoft Corporation in 2026
TCRX
Tscan Therapeutics Inc
$0.44
MSFT
Microsoft Corporation
$498.10
Key Metrics Comparison
| Metric | TCRX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $62.11M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | TCRX |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | -86.6% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze TCRX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TCRX or MSFT a better investment?
Comparing TCRX and MSFT: Tscan Therapeutics Inc has a market cap of $62.11M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TCRX and MSFT?
TCRX (Tscan Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TCRX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TCRX or MSFT?
MSFT has higher revenue growth at 18.4% vs -86.6% for TCRX.
Which company is more profitable: TCRX or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for TCRX.
Which is the larger company: TCRX or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $62.11M for TCRX.
Should I buy TCRX or MSFT in 2026?
Both TCRX and MSFT have investment merit. TCRX trades at $0.44 while MSFT trades at $498.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TCRX and MSFT stock?
Key differences: Market Cap ($62.11M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (-86.6% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy TCRX or MSFT in 2026?
The choice between TCRX and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TCRX and MSFT?
TCRX (Tscan Therapeutics Inc) has a market cap of $62.11M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.